Lucía Pérez-Lamas

6PUBLICATIONS
48CO-AUTHORS
Haematological tumoursMedical mycologyMolecular targetsInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|Apr 17, 2025
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.

Lucía Pérez-Lamas, Adrián Segura Diaz, Regina García Delgado

|May 16, 2023
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination.

Sara Rodríguez-Mora, Lucía Pérez-Lamas, Miriam Solera Sainero

|Feb 25, 2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors.

Lucía Pérez-Lamas, Alejandro Luna, Concepción Boque

|Apr 23, 2022
Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection.

Lorena Vigón, Adrián Sánchez-Tornero, Sara Rodríguez-Mora

|May 03, 2021
Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.

Lucía Pérez-Lamas, Gemma Moreno-Jiménez, María C Tenorio-Núñez

Pageof 1

Frequent Collaborators

5 joint publications

Valentín García-Gutiérrez

3 joint publications

Juan-Carlos Hernández-Boluda

3 joint publications

Manuel Pérez-Encinas

2 joint publications

Sara Rodríguez-Mora